ENTRY ID: SCALE-AMR-GLOBAL-001
Date added: 10/07/2026
Entry status: [ ] Draft [ ] Under review [x] Published
Submitted by: GSTIA Library Team
LLM: DeepSeek-R1
1. Solution Title
Establish a global ecological security governance framework to combat antimicrobial resistance driven by planetary disruption.
2. Step-by-Step Implementation Guide
This guide outlines a sequenced, multi-decade strategy for global governance institutions (UN, WHO, FAO, UNEP, IPCC, IPBES, World Bank, WTO, G20) and coalitions of nation-states to address antimicrobial resistance (AMR) as a global ecological security threat. The approach recognises that AMR emerges not only from clinical antibiotic overuse but is amplified by pollution, climate change, nutrient overabundance, ecosystem degradation, and the transboundary movement of pathogens and pollutants .
Step 1 – Establish a Global Commission on Ecological Security and Antimicrobial Resistance
- Action: The UN General Assembly, with support from WHO, FAO, UNEP, and the G20, mandates the creation of an independent High-Level Commission on Ecological Security and Antimicrobial Resistance.
- Responsible Actor: UN Secretary-General / WHO Director-General / FAO Director-General / UNEP Executive Director.
- Completion Looks Like: The Commission is formed with a 3-year mandate, comprising leading ecologists, epidemiologists, microbiologists, ecological economists, and security experts. Its core tasks are to:
- Formally recognise AMR as an ecological security threat driven by planetary disruption, not merely a public health issue .
- Develop a “Global Ecological AMR Framework” integrating environmental, agricultural, clinical, and veterinary dimensions.
- Map global AMR risk pathways, including the role of pollution (heavy metals, microplastics), climate change, nutrient overabundance, and ecosystem degradation in driving resistance emergence .
- Propose a “Global Deal” for a just transition to a post-antibiotic-resistant world.
Step 2 – Establish a Global Ecological AMR Surveillance and Early Warning System
- Action: Create a globally integrated surveillance network monitoring AMR emergence across environmental, agricultural, clinical, and veterinary sectors, with specific focus on environmental drivers (pollution, temperature, nutrient loading, ecosystem disruption).
- Responsible Actor: WHO / FAO / UNEP / World Organisation for Animal Health (WOAH) / World Bank.
- Completion Looks Like:
- Global environmental AMR surveillance network established at major water bodies, aquaculture sites, agricultural zones, and biodiversity hotspots, including monitoring of metal contamination (copper, zinc, lead, nickel, chromium) as co-drivers of antibiotic resistance .
- Global AMR data platform with open-access sharing, integrating environmental, climate, agricultural, and health data.
- Early warning indicators for:
- Emergence of novel AMR pathogens in environmental reservoirs.
- Climate-AMR interactions (temperature-resistance correlations) .
- Nutrient overabundance and biofilm hotspots where bacteria can be up to 1,000 times more resistant to antibiotics .
- Zoonotic spillover risks amplified by ecological disruption .
- Annual global “State of Ecological AMR” report to the UN General Assembly.
Step 3 – Regulate Global Pollution and Nutrient Overabundance as AMR Drivers
- Action: Establish binding global agreements to reduce pollution and nutrient loading that serve as environmental drivers of AMR emergence.
- Responsible Actor: UNEP / FAO / WHO / WTO / G20.
- Completion Looks Like:
- Global treaty on nitrogen and phosphorus runoff, with binding limits on agricultural and industrial discharges, given that nutrient overabundance promotes fungal pathogen growth and creates biofilm reservoirs for resistance .
- Global convention on heavy metal pollution, regulating discharges of copper, zinc, lead, nickel, and chromium into water bodies, as metal contamination co-selects for antibiotic resistance genes even in the absence of antibiotic exposure .
- Global plastics treaty that includes AMR provisions, given evidence that environmental microplastics provide breeding grounds for antibiotic resistance .
- Mandatory global wastewater treatment standards that remove both antibiotic residues and AMR-driving pollutants.
- Global ban on sub-therapeutic antibiotic use in animal agriculture and aquaculture.
Step 4 – Integrate AMR into Global Climate and Biodiversity Governance
- Action: Ensure that AMR is treated as a core component of global climate adaptation and biodiversity governance frameworks, recognising that climate change, biodiversity loss, and AMR are mutually reinforcing drivers of ecological insecurity.
- Responsible Actor: UNFCCC / CBD / IPCC / IPBES / WHO.
- Completion Looks Like:
- Nationally Determined Contributions (NDCs) under the Paris Agreement include AMR risk assessments and adaptation measures, recognising that climate change influences AMR through its impacts on microbial dynamics, host-pathogen interactions, and bacterial replication and mutation rates .
- Global biodiversity targets (post-2020 Global Biodiversity Framework) include AMR as a threat multiplier, given that ecosystem degradation is a shared driver of both biodiversity loss and AMR emergence .
- IPCC and IPBES assessments include AMR as a cross-cutting issue in their future reports.
- Extreme weather event planning (floods, droughts) incorporates AMR risk, given that such events disrupt sanitation systems and create conditions that can lead to greater antibiotic use and misuse .
Step 5 – Reform Global Agricultural and Aquaculture Systems to Reduce AMR Selection Pressure
- Action: Transform global agricultural and aquaculture systems to reduce the environmental selection pressure for AMR, addressing both antibiotic use and the ecological conditions that amplify resistance.
- Responsible Actor: FAO / WHO / WTO / World Bank / G20.
- Completion Looks Like:
- Global treaty on antibiotic use in livestock, aquaculture, and crop production, with binding reduction targets and phase-out of sub-therapeutic use.
- Global promotion of agroecological practices that reduce chemical inputs and carbon emissions, recognising that nature-based solutions can mitigate AMR risk through ecological processes .
- Global investment in sustainable manure management strategies (composting, anaerobic digestion) to reduce antibiotic residues in soil and water while simultaneously enhancing carbon sequestration and soil fertility .
- Global fund for constructed wetlands and mangrove restoration for treating agricultural and hospital wastewater, reducing pharmaceutical pollutants and antibiotic residues while restoring biodiversity .
- WTO rules revised to allow countries to impose trade restrictions on agricultural products from nations with high AMR risk.
Step 6 – Accelerate Global Natural Product Antibiotic Discovery and Development
- Action: Establish a global programme to accelerate the discovery, development, and equitable distribution of natural product antibiotics, recognising that approximately 70% of existing antibiotics are derived from natural sources and that natural compounds often target multiple bacterial pathways simultaneously, reducing the likelihood of resistance .
- Responsible Actor: WHO / World Intellectual Property Organization (WIPO) / UNDP / Wellcome Trust / G20.
- Completion Looks Like:
- Global fund for natural product antibiotic discovery, including:
- Bioprospecting from underexplored ecological niches and uncultured microorganisms, which account for 99% of global microbial diversity and represent a vast, largely untapped reservoir of novel antimicrobial compounds .
- Genome mining and modern analytical methods to identify biosynthetic gene clusters .
- Development of formulation advancements (e.g., nanoparticle encapsulation) to enhance bioavailability and activity of natural compounds .
- Global repository for natural antimicrobial compounds, with open-access data sharing.
- TRIPS flexibilities fully utilised to ensure equitable access to new antibiotics, particularly for developing countries.
- Global “Antibiotic Innovation and Access” treaty that decouples antibiotic R&D from patent-driven monopolies, using prize funds and advance market commitments instead.
- Global fund for natural product antibiotic discovery, including:
Step 7 – Launch a Global “One Health” AMR Action Framework with Just Transition Principles
- Action: Develop and implement a comprehensive global “One Health” AMR action framework that integrates human, animal, and environmental health sectors, with explicit attention to just transition principles.
- Responsible Actor: WHO / FAO / UNEP / WOAH / World Bank / UNDP.
- Completion Looks Like:
- Global AMR action plan with binding targets for reducing AMR prevalence in clinical, agricultural, and environmental settings, and monitoring their implementation.
- Procedural justice mechanisms ensuring inclusive decision-making in global AMR policy, particularly for developing countries and smallholder farmers who may be disproportionately affected by antibiotic use restrictions .
- Distributive justice considerations ensuring that the benefits and harms of AMR interventions are fairly distributed, given that the burden of AMR falls unequally on developing countries and vulnerable populations .
- Global “Just Transition” fund to support smallholder farmers, aquaculture workers, and pharmaceutical workers in transitioning to AMR-resilient practices.
- Place-based approaches and participatory monitoring, co-designed with communities rather than imposed as technical fixes .
Step 8 – Reform Global Financial Architecture to Account for AMR and Ecological Risk
- Action: Mandate that all global financial institutions (IMF, World Bank, BIS, commercial banks, pension funds, insurance companies, asset managers) assess and disclose their exposure to AMR and ecological risk.
- Responsible Actor: Financial Stability Board (FSB) / Bank for International Settlements (BIS) / IMF / World Bank / G20.
- Completion Looks Like:
- Global financial institutions required to conduct AMR stress tests, with scenarios including:
- 10 million annual AMR deaths by 2050, as projected .
- $11 trillion cumulative economic burden of AMR to 2050 .
- Disruption to agricultural, healthcare, and pharmaceutical supply chains.
- Increased sovereign debt defaults in AMR-vulnerable nations.
- Risk-weighting of assets to reflect AMR vulnerability (e.g., pharmaceutical supply chains, intensive agriculture, vulnerable healthcare systems).
- Global divestment mandates for public pension funds and sovereign wealth funds from high-AMR-risk industries (e.g., intensive livestock, polluting industries).
- Creation of a global “AMR Resilience Bond” market to finance AMR prevention and adaptation.
- Global financial institutions required to conduct AMR stress tests, with scenarios including:
Step 9 – Establish a Global “Ecological Debt” Settlement for AMR and Ecosystem Degradation
- Action: A global treaty to address historical and ongoing ecological debt, including reparations for AMR-related health impacts and support for AMR prevention in vulnerable nations.
- Responsible Actor: UN / WHO / UNEP / G20.
- Completion Looks Like:
- A global agreement that:
- Acknowledges the historical responsibility of high-income nations for ecological disruption that drives AMR .
- Provides for “AMR Loss and Damage” compensation for vulnerable nations.
- Establishes a global mechanism for technology transfer and capacity building for AMR prevention and natural product discovery.
- Includes binding targets for pollution reduction, antibiotic use reduction, and AMR surveillance.
- Ensures that the transition does not create new forms of inequality or exploitation.
- A global agreement that:
Step 10 – Establish a Global “Truth and Reconciliation” Process for Ecological and Health Narratives
- Action: A multi-stakeholder global dialogue to challenge the dominant siloed narrative that AMR is merely a public health or clinical issue, and to build a new, shared understanding of AMR as an ecological security threat.
- Responsible Actor: WHO / UNESCO / UN / Civil Society Organisations (CSOs).
- Completion Looks Like:
- A global campaign to promote ecological and health literacy, explaining the role of pollution, climate change, and ecosystem degradation in AMR emergence .
- The development of new narratives in media, education, and public discourse that move beyond siloed thinking and embrace a One Health, ecological security perspective.
- The fostering of a global civil society movement (e.g., a “Global Ecological Health Alliance”) to advocate for these reforms.
3. Polycrisis Strand(s)
Primary strand: Food, health and disease
Interaction effects with other strands:
- Climate change: Climate change influences AMR directly through its impacts on microbial dynamics, host-pathogen interactions, and bacterial replication and mutation rates, while also modifying habitat, distribution, evolution, and transmission of climate-sensitive pathogens .
- Pollution, toxics and waste: Pollution (heavy metals, microplastics, nutrients) is a direct environmental driver of AMR emergence, with antibiotic resistance genes detected in bacterial samples that had no known antibiotic exposure but high concentrations of metal contamination .
- Biodiversity loss: Ecosystem degradation is a shared driver of both biodiversity loss and AMR emergence, and the loss of biodiversity reduces the resilience of ecosystems to pathogen outbreaks .
- Inequality: The burden of AMR falls unequally on developing countries and vulnerable populations, with deaths in children under 5 from sepsis having dropped by 60% since 1990, but the proportion of those infants with AMR infections has increased .
- Governance, peace and conflict: Ecological disruption is a driver of instability, with AMR posing risks to social cohesion, political stability, and security .
- Energy and mineral resources: Nutrient overabundance (nitrogen and phosphorus) from fertiliser use is a key driver of fungal pathogen proliferation and biofilm formation .
- Globalisation and finance: The global economic burden of AMR to 2050 is estimated at $11 trillion, with profound implications for global financial stability and development .
4. Scale Category
| Scale | Primary? | Enabling role? |
|---|---|---|
| Individual | Yes | |
| Family / Household | Yes | |
| Community / Village | Yes | |
| City / Region | Yes | |
| Nation State | Yes | |
| Global | Yes |
Notes on scale interaction: “Requires a global-level governance framework to enable and coordinate change at all lower scales. Without global rules on pollution, antibiotic use, and trade, national-level reforms can be undermined by free-riding and a ‘race to the bottom.’ AMR is a global public good problem requiring global solutions.”
5. Dewey Decimal Classification
Primary DDC: 616.9041 – Antimicrobial resistance and drug-resistant pathogens
Secondary DDC(s): 363.7 – Environmental problems; 333.7 – Natural resources, energy, and environment; 338.927 – Sustainable development; 577 – Ecology; 327.17 – International security; 341.7 – International environmental law; 636.089 – Veterinary medicine
Subject headings (LC or local): “Antimicrobial resistance – international cooperation”, “Ecological security”, “One Health”, “Global environmental health”, “Drug resistance in microorganisms”, “Pollution – health aspects – international cooperation”, “Climate change – health aspects”, “Biosphere – security implications”, “Transboundary environmental risks”
6. Regional Applicability
Evidenced implementations:
- WHO Global Action Plan on AMR: A partial precedent for global AMR governance.
- FAO/WHO/WOAH One Health approach: A precedent for integrated human, animal, and environmental health policy.
- UNEP Global Plastics Treaty (in negotiation): A potential precedent for global pollution governance with AMR relevance.
- EU Green Deal and Farm to Fork Strategy: A regional example of integrated agricultural and environmental policy .
- UNFCCC Paris Agreement: A precedent for global climate governance (though insufficient).
Climatic/geographic scope: [ ] Tropical [ ] Temperate [ ] Arid [ ] Arctic/sub-arctic [ ] Coastal [x] All
Political economy prerequisites: “Requires a high degree of international political will and cooperation. It is a ‘public good’ that is vulnerable to free-riding by powerful nations or corporations. The absence of a binding global authority makes this the most challenging scale of implementation. Requires a global scientific consensus and a public that can be mobilised around health and ecological issues.”
Contraindications: “Opposition from powerful nations (especially agricultural exporters and major polluters) and transnational corporations (especially in pharmaceuticals, agribusiness, and extractive industries) that benefit from the current system is likely to be intense. A unilateral approach by one country may lead to capital flight and carbon leakage.”
7. Cost Estimate
| Cost tier | Indicative range | Basis |
|---|---|---|
| Pilot / proof of concept | $100 million – $500 million | Cost of establishing the Global Commission, surveillance network, and initial diplomacy. |
| Community-scale deployment | N/A | Not applicable at this scale. |
| City/regional scale | N/A | Not applicable at this scale. |
| National rollout | N/A | Not applicable at this scale. |
| Global rollout | $500 billion – $5 trillion+ | The cost of a global AMR prevention and adaptation programme, including pollution reduction, agricultural reform, healthcare system strengthening, and natural product discovery. This is not a cost but a strategic investment and reallocation of global financial flows. The resources required are already in the global economy but are currently directed towards reactive healthcare, polluting industries, and agricultural subsidies. |
Cost notes: “This is a global public investment strategy, not a traditional ‘cost.’ The resources required are already in the global economy but are currently directed towards value extraction (e.g., polluting industries, reactive healthcare). The solution is about redirecting global capital flows towards AMR prevention. Initial ‘costs’ are for diplomacy, institution-building, and technical assistance, which are relatively low. The ‘investment’ is in the hundreds of billions to trillions of dollars but is designed to generate a massive positive return in terms of human health, economic productivity, and global stability. The cost of inaction (unchecked AMR) is estimated at $11 trillion cumulative economic burden to 2050 .”
Funding mechanisms used in existing implementations: “Global taxes (financial transaction tax, carbon tax, polluter-pays taxes), redirected subsidies (away from intensive agriculture and towards sustainable practices), reallocation of Special Drawing Rights (SDRs) at the IMF, and contributions from member states based on GDP and ecological footprint.”
8. Timescale Estimate
Time to initial implementation: 5-10 years (to establish the Global Commission, reach an international consensus on key reforms, and negotiate a treaty framework).
Time to measurable impact: 10-15 years (to see first effects on global AMR prevalence, pollution levels, and antibiotic use).
Time horizon of full benefit: 25-50 years (a generational shift to a new global ecological health paradigm).
Short-term vs long-term tension note: “This is a long-term project of global institutional transformation. In the short term, it requires significant political capital and will face immense opposition from entrenched interests. The ‘sacrifice’ is the loss of profits for polluting and intensive agricultural industries, and a loss of sovereignty for nations (especially those with large agricultural and pharmaceutical sectors). The long-term benefit is the avoidance of a ‘pre-penicillin’ era, with all its implications for health, economic productivity, and social stability .”
9. Evidence Base
Primary source(s): Schoonover, R. and Smith, D. (2023). Five Urgent Questions on Ecological Security. SIPRI Insights on Peace and Security, No. 2023/05. Stockholm International Peace Research Institute.
Supporting source(s):
- Review on Antimicrobial Resistance, Chaired by Jim O’Neill (2016). Tackling Drug-resistant Infections Globally: Final Report and Recommendations.
- Adekannbi, A. O., Olawuni, O. G. and Olaposi, A. V. (2021). Metal contamination and coexistence of metal and antibiotic resistance in Vibrio species recovered from aquaculture ponds. Bulletin of the National Research Centre, 45(1).
- Rukomeza, G. et al. (2025). Nature-Based Solutions to Promote Just Transitions for Climate Change and Antimicrobial Resistance. Public Humanities, Cambridge University Press.
- Barry, S. M. (2025). Rethinking natural product discovery to unblock the antibiotic pipeline. Future Microbiology, Taylor & Francis.
- Yang, Y-Y. et al. (2025). A novel strategy for combating multidrug-resistant bacteria: Natural products from uncultured microorganisms. European Journal of Medicinal Chemistry, ScienceDirect.
- MacFadden, D. R. et al. (2018). Antibiotic resistance increases with local temperature. Nature Climate Change, 8, 510-514.
- Li, W. et al. (2023). Association between antibiotic resistance and increasing ambient temperature in China. The Lancet Regional Health-Western Pacific, 30.
- WHO (2023). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. World Health Organization.
- UNEP (2023). Bracing for Superbugs: Strengthening Environmental Action in the One Health Response to Antimicrobial Resistance. United Nations Environment Programme.
Evidence quality: [x] Peer-reviewed [x] Grey literature [x] Practitioner case study [x] Modelled projection
Known counter-evidence or limitations: “This is a systemic solution that is still emerging in policy practice. The evidence for individual components is strong (AMR surveillance, pollution regulation, natural product discovery), but the integration of AMR as a global ecological security issue across health, environment, and security sectors is novel and untested at global scale. The primary limitation is political: the dominance of siloed global governance (WHO vs UNEP vs FAO vs Security Council) and resistance from vested interests in high-polluting and intensive agricultural industries. The precautionary principle applies: decision makers should not wait until scientific uncertainty is eliminated before acting .”
Supporting media (external links only):
- https://www.sipri.org/sites/default/files/2023-04/five_urgent_questions_0.pdf – Full SIPRI report on Five Urgent Questions on Ecological Security.
- https://www.sipri.org/media/press-release/2023/poorly-understood-environmental-trends-could-become-tomorrows-security-threats – SIPRI press release summarising the report’s findings.
- https://ecologicalfutures.com/just-released-five-urgent-questions-on-ecological-security/ – Rod Schoonover’s blog on the report.
- https://dansmithsblog.com/2023/04/24/ecological-security-five-questions/ – Dan Smith’s blog summarising the report.
- https://www.unep.org/interactives/bracing-for-superbugs/ – UNEP interactive report on environmental action for AMR.
- https://www.who.int/initiatives/glass – WHO Global Antimicrobial Resistance and Use Surveillance System.
Link verification date: 10/07/2026
10. Implementation Indicators
Output indicators:
- Number of nations adopting the Global Ecological AMR Framework.
- Number of nations implementing binding pollution and nutrient reduction targets.
- Number of nations with mandatory environmental AMR surveillance systems.
- Capitalisation of the Global AMR Prevention and Adaptation Fund ($ billions).
- Number of nations with just transition programmes for smallholder farmers.
- Number of natural product antibiotic candidates in development globally.
- Number of nations with AMR integrated into NDCs and biodiversity targets.
Outcome indicators:
- Global AMR mortality rate (per 100,000 population).
- Global incidence of antibiotic-resistant infections (per 100,000).
- Global healthcare costs attributable to AMR ($).
- Global agricultural productivity losses attributable to AMR.
- Global water and soil quality indicators (nutrient loads, metal concentrations, microplastics).
- Global progress on WHO AMR action plan targets.
- Global antibiotic use in livestock and aquaculture (tons per year).
- Global greenhouse gas emissions (as a co-benefit of agricultural reform).
- Global biodiversity indicators (as a co-benefit of ecosystem restoration).
Reporting mechanism: “An annual report by the Global Commission on Ecological Security and Antimicrobial Resistance (or a successor body, e.g., a UN Security Council committee or a new UN agency) to the UN General Assembly, assessing the performance of the new global governance framework against the indicators above.”
11. Related Entries
- GSTIA Entry: Establish a national ecological security framework to combat antimicrobial resistance (Nation State Scale)
- GSTIA Entry: Establish a global ecological economic governance framework that recognises planetary limits (Global Scale)
- GSTIA Entry: Global Ecological AMR Surveillance and Early Warning System
- GSTIA Entry: Global Treaty on Pollution and Nutrient Overabundance
- GSTIA Entry: Global Antibiotic Innovation and Access Treaty
- GSTIA Entry: Global “One Health” AMR Action Framework
- GSTIA Entry: Global Just Transition Fund for AMR
- GSTIA Entry: Global Ecological Debt Settlement for AMR
- GSTIA Entry: Planetary Boundaries Governance Framework
- GSTIA Entry: Doughnut Economics National Transition Plan